1. Home
  2. PAYC vs PRAX Comparison

PAYC vs PRAX Comparison

Compare PAYC & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paycom Software Inc.

PAYC

Paycom Software Inc.

HOLD

Current Price

$123.22

Market Cap

6.3B

Sector

Technology

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$299.68

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYC
PRAX
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
7.1B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
PAYC
PRAX
Price
$123.22
$299.68
Analyst Decision
Buy
Strong Buy
Analyst Count
15
15
Target Price
$168.79
$572.13
AVG Volume (30 Days)
840.1K
526.0K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
1.17%
N/A
EPS Growth
N/A
N/A
EPS
3.04
N/A
Revenue
$433,047,000.00
N/A
Revenue This Year
$8.79
N/A
Revenue Next Year
$7.48
$7,758.26
P/E Ratio
$41.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$104.90
$37.25
52 Week High
$248.95
$366.52

Technical Indicators

Market Signals
Indicator
PAYC
PRAX
Relative Strength Index (RSI) 37.99 53.31
Support Level $118.80 $282.49
Resistance Level $126.91 $342.62
Average True Range (ATR) 5.31 21.67
MACD -1.89 3.34
Stochastic Oscillator 13.22 75.25

Price Performance

Historical Comparison
PAYC
PRAX

About PAYC Paycom Software Inc.

Paycom is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. The firm's solutions are available on a unified, modular platform, and customers are billed for access on a subscription basis. Paycom's customer base skews toward the midmarket and is primarily based in North America. As of 2025, the firm manages records for 7.4 million employees across more than 20,000 clients on a parent-company-group basis.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: